Abrezekimab Biosimilar (IL-13 Reference Antibody)
Abrezekimab (VR 942) contains CDP7766, a humanized, high-affinity, neutralizing, anti-human-IL-13 antibody fragment that binds to IL-13. Abrezekimab prevents binding to the IL-13Rα1 subunit. Abrezekimab can be used in research of asthma.
Product Specifications
Target
Abrezekimab Biosimilar (Anti-IL-13 Reference Antibody)
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Purity
>98%
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
VAng-Ly2396-500gEcoli 500 µg (E. coli)
Recombinant Campylobacter Jejuni rpsD Protein (aa 1-208) (strain 81116 / NCTC 11828)
Sign In for Pricing
View Details HP201596 200 Reactions
OR10V1 Human qPCR Primer Pair (NM_001005324)
Sign In for Pricing
View Details 